12. Quality of life scores.
Technique | Study | Quality of life score | |||||||
V‐Q/SymQ | AVVSS | CIVIQ2 | SF‐12 | SF‐36 | RAND‐36 | EQ‐5D | SF‐6D | ||
EVLA versus RFA | Nordon 2011 | ✓ | |||||||
Rasmussen 2011 | ✓ | ✓ | |||||||
Recovery 2009 | ✓ | ||||||||
Shepherd 2010 | ✓ | ||||||||
EVLA versus EVSA | LAST 2014 | ✓ | |||||||
EVLA versus UGFS | Magna 2013 | ✓ | ✓ | ||||||
Rasmussen 2011 | ✓ | ✓ | |||||||
Vernermo 2016 | ✓ | ||||||||
EVLA versus CA | Calik 2019 | ✓ | |||||||
EVLA versus MOCA | Vähäaho 2019 | ✓ | |||||||
EVLA versus HL/S (surgery) |
Darwood 2008 | ✓ | |||||||
Flessenkämper 2013 | ✓ | ||||||||
HELP‐1 2011 | ✓ | ✓ | ✓ | ✓ | |||||
Magna 2013 | ✓ | ✓ | |||||||
Pronk 2010 | ✓ | ||||||||
Rasmussen 2007 | ✓ | ✓ | |||||||
Rasmussen 2011 | ✓ | ✓ | |||||||
RELACS 2012 | ✓ | ||||||||
Vernermo 2016 | ✓ | ||||||||
RFA versus UGFS | Rasmussen 2011 | ✓ | ✓ | ||||||
RFA versus CA | Morrison 2015 | ✓ | ✓ | ||||||
RFA versus MOCA | Lane 2017 | ✓ | ✓ | ||||||
MARADONA 2019 | ✓ | ✓ | |||||||
Vähäaho 2019 | ✓ | ||||||||
RFA versus HL/S (surgery) | EVOLVeS 2003 | ✓ | |||||||
Rasmussen 2011 | ✓ | ✓ | |||||||
Rautio 2002 | ✓ | ||||||||
Subramonia 2010 | ✓ | ✓ | |||||||
RFA versus UGFS | Rasmussen 2011 | ✓ | ✓ | ||||||
UGFS versus HL/S (surgery) |
FOAM 2010 | ✓ | |||||||
Magna 2013 | ✓ | ✓ | |||||||
Rasmussen 2011 | ✓ | ✓ | |||||||
Vernermo 2016 | ✓ |
AVVSS: Aberdeen Varicose Vein Symptom Severity Score CA: cyanoacrylate glue CIVIQ2: Chronic Venous Insufficiency Quality of Life Questionnaire EQ‐5D: EuroQol‐5D EVLA: endovenous laser ablation EVSA: endovenous steam ablation HL/S: high ligation and stripping MOCA: mechanochemical ablation RAND‐36: Short term RAND‐36 (validated for Finland) RFA: radiofrequency ablation SF‐12: Medical Outcomes Study Short Form 12 SF‐36: Medical Outcomes Study Short Form 36 SF‐6D: variation of the Medical Outcomes Study Short Form 36 UGFS: ultrasound‐guided foam sclerotherapy V‐Q/SymQ: VEINES‐QoL/Sym questionnaire